MedTrace Logo

Lormetazepam Versus Midazolam in Critically Ill Patients: a Retrospective Cohort Trial

NCT04408911 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3314

Last updated 2020-05-29

No results posted yet for this study

Summary

The aim of this retrospective cohort study is to evaluate the effect of lormetazepam versus midazolam on hospital mortality, intensive care unit outcomes and sedation management.

The hypothesis is that patients receiving midazolam have a 5% higher hospital mortality in comparison to patients receiving lormetazepam.

Conditions

  • Critical Illness

Interventions

DRUG

Midazolam vs. Lormetazepam

In this retrospective analysis we compared critically ill ICU patients receiving midazolam to those receiving lormetazepam.

Sponsors & Collaborators

  • Charite University, Berlin, Germany

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-01
Primary Completion
2018-12-31
Completion
2018-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04408911 on ClinicalTrials.gov